Company intelligence / Profile preview

Easywell Biomedicals

Hsinchu City, Taiwaneasywellbio.com ↗
Ownership
Private
Development stage
Other
01

Overview

Easywell Biomedicals is a Taiwan-based healthcare company active in pharmaceuticals, regenerative medicine, and medical devices. The company develops and commercializes active pharmaceutical ingredients, dosage-form pharmaceuticals, and medical products, and operates U.S. pharmaceutical development and cGMP manufacturing through its Tulex subsidiary. Its disclosed pipeline includes 505(b)(2) reformulations, high-barrier generics, and marketed products such as HH-001 sacubitril/valsartan tablets in China. Easywell also highlights proprietary formulation and drug-delivery technologies focused on bioavailability enhancement and programmable release profiles. The company is publicly traded in Taiwan under stock code 1799 and appears to be expanding through partnerships, licensing, and share-swap M&A activity.

Therapeutic areas
ImmunologyCardiovascularEndocrinologyNeurologyRare DiseasesPsychiatry
Modalities
Small moleculeDeviceCell therapyDrug delivery therapyTransdermal patchModified-release oral dosage formOral liquid extended-release formulation
Industry
Biotech
02

Drug pipeline

6 assets

TLX-008

Preclinical

5 more assets in the full pipeline.

03

Partnerships

Eton PharmaceuticalsArtisan TherapeuticsTTY BiopharmGenovate Biotechnology

Beyond the preview

Go deeper on Easywell Biomedicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Easywell Biomedicals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call